Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet.

New first-in-human data highlight the potential of pants designed to improve the quality of MRI-based cardiac stress tests.

Patients treated with the Sapien 3 platform from Edwards Lifesciences and the Evolut platform from Medtronic were linked to more similarities than differences after six years. This was a single-center study, researchers noted, but it does provide an in-depth look at the safety and effectiveness of TAVR.

However, eligibility alone does not mean a patient will benefit from treatment.

Sola is a rupture-resistant balloon catheter that uses laser energy to deliver 360-degree pressure with each pulse. It was designed to address limitations the company saw in current calcium-modification devices.

Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time. 

The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.

"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.

The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.

Consulting firm Vizient is forecasting continued growth in the specialty, driven by shifts in where patients receive care, new therapies that require imaging and a rapidly aging population. 

The Department of Health and Human —under the direction of Secretary Robert F. Kennedy Jr.—has released all 17 members of the Advisory Committee on Immunization Practices (ACIP), citing a need to enact President Donald Trump's agenda of restoring science to a "gold standard."